Literature DB >> 18061462

Amphiphilic chitosan nanosphere: studies on formation, toxicity, and guest molecule incorporation.

Rangrong Yoksan1, Suwabun Chirachanchai.   

Abstract

Amphiphilic chitosan developed by conjugating hydrophobic phthalimido groups and hydrophilic poly (ethylene glycol) chains gives a well-dispersed colloidal solution in polar solvents and shows a regular nano-sized spherical structure ( approximately 200 nm) with negatively charged surface (-31.24+/-4.85 mV). An in vivo acute oral toxicity test confirms the non-toxicity of the chitosan nanosphere with LD(50) higher than 2000 mg/kg body weight. A success of incorporating amine molecules into the nanosphere declares that the heterogeneous incorporation system is more effective than the homogeneous ones. The study on guest molecule incorporation using alkylamines and carboxylic acid as models suggests requirements that the guest be hydrophobic and positively charged. TGA study clarifies that the weight loss at 250-300 degrees C relating to the amount of guest incorporation via heterogeneous system is as high as 42.3%, whereas those of homogeneous systems are about 16.86-28.27%. The nanosphere size is significantly changed after guest incorporation, that is, from 200 nm to approximately 500-1000 nm.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18061462     DOI: 10.1016/j.bmc.2007.11.037

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  4 in total

Review 1.  Adjuvants for allergy immunotherapeutics.

Authors:  Carlos Gamazo; Carmen D'Amelio; Gabriel Gastaminza; Marta Ferrer; Juan M Irache
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

2.  Chitosan nanoparticles for the linear release of model cationic Peptide.

Authors:  Anna Maria Piras; Stefania Sandreschi; Giuseppantonio Maisetta; Semih Esin; Giovanna Batoni; Federica Chiellini
Journal:  Pharm Res       Date:  2015-01-06       Impact factor: 4.200

3.  Swellable microparticles as carriers for sustained pulmonary drug delivery.

Authors:  Ibrahim M El-Sherbiny; Shayna McGill; Hugh D C Smyth
Journal:  J Pharm Sci       Date:  2010-05       Impact factor: 3.534

4.  Immunoadjuvant potential of cross-linked dextran microspheres mixed with chitosan nanospheres encapsulated with tetanus toxoid.

Authors:  Haniyeh Pirouzmand; Bahman Khameneh; Mohsen Tafaghodi
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.